Delta Plus variant may defeat vaccines, antibodies and infection immunity, warns Prof Jameel

The Delta Plus variant may soon grow to evade Covid-19 vaccines and even immunity gained from previous infections, warned Prof Shahid Jameel, a former member of INSACOG.

While evidence shows that the Delta variant (B.1.617.2) dominated during the second wave of Covid-19 in India, there is a growing concern about the parent variant's most recent mutation, known as the Delta Plus or AY.01.

Experts have said that the Delta Plus variant could evade both vaccine and infection immunity. One of India’s top virologists and former member of the INSACOG, Prof Shahid Jameel fears the variant would be evading both immunities from Covid vaccination as well as immunity generated by earlier infections.

Prof Jameel explained that this is because Delta Plus possesses not only all of the characteristics of the original Delta variant but also a mutation known as K417N, which was discovered in the Beta variant in South Africa.

“It’s well-established that the Beta variant of concern evades vaccines much better than the Alpha variant or even the Delta variant,” he said. This is evidenced by the fact that the South African government had returned a consignment of AstraZeneca vaccines, claiming that it was ineffective against the variant there.

Story Courtesy

https://www.indiatoday.in/coronavirus-outbreak/story/delta-plus-variant-may-defeat-vaccines-prof-jameel-1817761-2021-06-22

Tags : #ProfJameel #VaccineImmunity #DeltaVariant #IndiaToday #INSACOG #CovidVaccine #Antibody #Immunity

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024
Is Your Daily Turmeric Dose Doing More Harm Than Good: Alarming Lead Levels in Indian TurmericNovember 13, 2024
Moscow Researchers Develop Russia's Pioneer Lumbosacral Spine Phantom for Anesthesia Ultrasound TrainingNovember 12, 2024
World Pneumonia Day: How Pneumonia Continues to Steal Lives and What We Can Do About ItNovember 12, 2024
From Darkness to Clarity: How Stem Cell Transplants Are Offering New Hope for Corneal BlindnessNovember 12, 2024
Daytime Sleepiness and Dementia: Is Napping in the Afternoon Putting You at Risk?November 12, 2024
GET WEDDING-READY WITH KAY BEAUTY: KATRINA KAIF’S TOP PICKS FOR BRIDES & BRIDESMAIDSNovember 11, 2024
Amrita Vishwa Vidyapeetham Students Win Global All-Track Grand Prize at HackHarvard 2024 Organized by Harvard University StudentsNovember 11, 2024
Algorand Foundation Announces its Investment in 5 Startups from the Inaugural Startup Lab Program at T-HubNovember 11, 2024
DOST, DTI & DICT join forces for Philippine Startup Week 2024 to Ignite Filipino InnovationNovember 11, 2024
Firewall gender equality from threats like anti-rights Geneva Consensus DeclarationNovember 11, 2024
Delhi’s Air Crisis: How Toxic Air and Pollution Are Still Threatening Health and Life QualityNovember 11, 2024
Are You at Risk? AI Data Exposes Unseen Triggers of Diabetes in Our EnvironmentNovember 11, 2024
Why Children in High-Risk Areas Are Paying the Price for TB Neglect?November 11, 2024
The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening InfectionsNovember 09, 2024
Is Your Gut Telling You Something? The Bacterial Clues to Early Rheumatoid ArthritisNovember 09, 2024